Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.
2.

The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol.

Ye Y, Meyer HH, Rapoport TA.

Nature. 2001 Dec 6;414(6864):652-6.

PMID:
11740563
3.

VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration.

Hirabayashi M, Inoue K, Tanaka K, Nakadate K, Ohsawa Y, Kamei Y, Popiel AH, Sinohara A, Iwamatsu A, Kimura Y, Uchiyama Y, Hori S, Kakizuka A.

Cell Death Differ. 2001 Oct;8(10):977-84.

4.

An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin.

Imai Y, Soda M, Inoue H, Hattori N, Mizuno Y, Takahashi R.

Cell. 2001 Jun 29;105(7):891-902.

5.

Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival.

Harding HP, Zeng H, Zhang Y, Jungries R, Chung P, Plesken H, Sabatini DD, Ron D.

Mol Cell. 2001 Jun;7(6):1153-63.

6.

Impairment of the ubiquitin-proteasome system by protein aggregation.

Bence NF, Sampat RM, Kopito RR.

Science. 2001 May 25;292(5521):1552-5.

7.

Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.

Waelter S, Boeddrich A, Lurz R, Scherzinger E, Lueder G, Lehrach H, Wanker EE.

Mol Biol Cell. 2001 May;12(5):1393-407.

9.

Polyglutamine and CBP: fatal attraction?

McCampbell A, Fischbeck KH.

Nat Med. 2001 May;7(5):528-30. No abstract available.

PMID:
11329046
10.

Beyond the Qs in the polyglutamine diseases.

Orr HT.

Genes Dev. 2001 Apr 15;15(8):925-32. Review. No abstract available.

11.

ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis.

Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T, Ichijo H.

EMBO Rep. 2001 Mar;2(3):222-8.

12.

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.

Nucifora FC Jr, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, Takahashi H, Tsuji S, Troncoso J, Dawson VL, Dawson TM, Ross CA.

Science. 2001 Mar 23;291(5512):2423-8.

13.

Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases.

Sherman MY, Goldberg AL.

Neuron. 2001 Jan;29(1):15-32. Review. No abstract available.

14.

Translational control by the ER transmembrane kinase/ribonuclease IRE1 under ER stress.

Iwawaki T, Hosoda A, Okuda T, Kamigori Y, Nomura-Furuwatari C, Kimata Y, Tsuru A, Kohno K.

Nat Cell Biol. 2001 Feb;3(2):158-64.

PMID:
11175748
15.

Polyglutamine disease and neuronal cell death.

Paulson HL, Bonini NM, Roth KA.

Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):12957-8. No abstract available.

16.
17.

IRE1 and efferent signaling from the endoplasmic reticulum.

Urano F, Bertolotti A, Ron D.

J Cell Sci. 2000 Nov;113 Pt 21:3697-702. Review.

18.

The ER translocon and retrotranslocation: is the shift into reverse manual or automatic?

Johnson AE, Haigh NG.

Cell. 2000 Sep 15;102(6):709-12. Review. No abstract available.

19.

EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome.

Del├ępine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, Julier C.

Nat Genet. 2000 Aug;25(4):406-9.

PMID:
10932183
20.

Perk is essential for translational regulation and cell survival during the unfolded protein response.

Harding HP, Zhang Y, Bertolotti A, Zeng H, Ron D.

Mol Cell. 2000 May;5(5):897-904.

Supplemental Content

Support Center